Polen Capital Management
PRAX icon

Polen Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Polen Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Sell
7,252
-2,791
-28% -$884K 0.02% 113
2026
Q1 		$3.24M Buy
+10,043
New +$3.11M 0.02% 71

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Polen Capital Management's PRAX Position: Q2 2026 in Review

Polen Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 28% in Q2 2026, selling an estimated $884K and leaving 7,252 shares worth $2.43M. The position accounts for 0.02% of the portfolio, ranked #113.

Polen Capital Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.24M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Polen Capital Management held 7,252 shares of Praxis Precision Medicines worth $2.43M as of Q2 2026.
  • Polen Capital Management sold 2,791 Praxis Precision Medicines shares in Q2 2026, an estimated $884K.
  • Praxis Precision Medicines made up 0.02% of Polen Capital Management's portfolio in Q2 2026, its #113 holding.
  • Polen Capital Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Polen Capital Management's Praxis Precision Medicines position peaked at $3.24M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.